July 2, 2018 Price forecast | 2 weeks: -0.17% | 1 month: -0.19% | 3 months: -1.40%


MGLN stock forecast

Our latest prediction for Magellan Health, Inc.'s stock price was made on the July 2, 2018 when the stock price was at 96.50$.

In the short term (2weeks), MGLN's stock price should underperform the market by -0.17%. During that period the price should oscillate between -4.79% and +4.78%.

In the medium term (3months), MGLN's stock price should underperform the market by -1.40%. During that period the price should oscillate between -12.28% and +13.51%.


About Magellan Health, Inc.

Magellan Health, Inc. engages in the healthcare management business. It operates through the following segments: Healthcare, Pharmacy Management and Corporate. The Healthcare segment comprises of the Commercial and Government reporting units. The Pharmacy Management segment offers products and solutions that provide clinical and financial management of pharmaceuticals paid under both the medical and the pharmacy benefit.The Corporate segment covers amounts not allocated to the Healthcare and Pharmacy Management segments. The company was founded in 1969 and is headquartered in Phoenix, AZ.

At the moment the company generates 7164M USD in revenues.

On its last earning announcement, the company reported a profit of 4.26$ per share.

The book value per share is 53.71$

Magellan Health, Inc. website


Three months stock forecastJuly 2, 2018


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
7164M 3.80% 144M 2.00% 107M 4.26 - - 25M 53.71 84M -66M 18M